Recs

1

The 15 Most-Watched Life-Sciences Stocks

People watch stocks for different reasons -- they're waiting for a dip in price, watching for a specific catalyst, gathering all the news and information that might affect stocks they already own, or considering a sell. Regardless of their motivation, we can better understand market sentiment by seeing who's watching what. With the Fool's free My Watchlist service, we have tens of thousands of people telling us the businesses that have, for whatever reason, piqued their interest.

With this data we have come up with a new metric, watch interest, to inform investors what stocks their peers keep tabs on in each industry. In the case of the life-sciences industry, watch interest is the percentage of people keeping an eye on life sciences stocks in general who are specifically watching each company. By looking at what stocks people are most interested in within an industry, you can get ahead of the curve by finding hot stocks that you might have otherwise overlooked.

The most-watched life-sciences stock is ...
Looking at the aggregate data, we see that Agilent Technologies (NYSE: A  ) is above the rest in terms of watch interest and for good reason. As CAPS player sintellectualres wrote last month:

Things need to be measured. Agilent is the measurer. In a world of technology and innovation, low tolerances are key, and Agililent ensures.

Here are the rest of the top 15 most-watched companies in the industry, and their watch interest, along with the stocks' CAPS rating to show the sentiment of our investing community.

Rank

Company

Market Cap (Millions)

CAPS Rating (out of 5)

Watch Interest

1 Agilent Technologies $12,735 *** 13.8%
2 Illumina (Nasdaq: ILMN  ) $6,597 **** 10.1%
3 Pacific Biosciences of California (Nasdaq: PACB  ) $347 **** 9.5%
4 Sequenom (Nasdaq: SQNM  ) $582 *** 6.9%
5 Thermo Fisher Scientific (NYSE: TMO  ) $20,552 ***** 5.9%
6 Techne (Nasdaq: TECH  ) $2,675 ***** 5.3%
7 Life Technologies (Nasdaq: LIFE  ) $7,563 *** 4.3%
8 Pharmaceutical Product Development (Nasdaq: PPDI  ) $3,022 ***** 3.6%
9 Harvard Bioscience $128 ***** 3.5%
10 Affymetrix (Nasdaq: AFFX  ) $336 ** 3.4%
11 BioDelivery Sciences International $105 *** 2.3%
12 Waters (NYSE: WAT  ) $7,127 **** 2.0%
13 PerkinElmer (NYSE: PKI  ) $2,537 ***** 2.0%
14 Covance (NYSE: CVD  ) $3,103 **** 1.5%
15 ICON (Nasdaq: ICLR  ) $1,221 ***** 1.5%

Sources: The Motley Fool, Motley Fool CAPS.

Whether you're keeping an eye on the industry stalwarts like Agilent or are watching an up-and-comer like Harvard Bioscience, it pays to watch. We can help you keep tabs on your companies with My Watchlist, our free, personalized stock tracking service. Get started now!

The Steve Jobs Betrayal
You may already know that in the final year of his life, Jobs revealed a stunning betrayal — and told his biographer, "I will spend my last dying breath... and every penny of Apple's $40 billion in the bank to right this wrong." What was it that made Jobs so irate — and why could it make a few in-the-know investors some major profits over the coming months and years?

Enter your email address below to find out what made Jobs so enraged!

Follow Dan Dzombak on Twitter at @DanDzombak to check out his musings and see what articles he finds interesting.

The Motley Fool owns shares of ICON. Motley Fool newsletter services have recommended buying shares of Techne, Pacific Biosciences of California, Illumina, Thermo Fisher Scientific, and Pharmaceutical Product Development. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On August 16, 2011, at 7:58 AM, srimox wrote:

    Many of these companies are quite compelling. Illumina has made many impressive innovations that could make it a very interesting buy as they continue to create products which are extremely technologically advanced. However out of all of these companies I think that Techne is the most interesting. They build the proteins that are needed by drug companies and universities and government research centers to run tests and to produce the medicines. It is an extremely lucrative business which leaves them with an extremely impressive 57% operating margin, and return on equity at about 20%. Especially now that labs have more money which they can use to fund more research Techne's sales should rise. I wrote an entire article about Techne on my blog which you can read if you would like at this link: http://teenstockadvisor.wordpress.com/2011/08/15/techne-tech...

Add your comment.

Compare Brokers

Fool Disclosure

DocumentId: 1538692, ~/Articles/ArticleHandler.aspx, 5/26/2012 2:15:19 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 16 hours ago Sponsored by:
DOW 12,454.83 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
NASD 2,837.53 -1.85 -0.07%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/25/2012 4:00 PM
A $41.01 Down -0.01 -0.02%
Agilent Technologi… CAPS Rating: ****
AFFX $4.96 Up +0.03 +0.61%
Affymetrix CAPS Rating: ***
CVD $46.55 Up +0.45 +0.98%
Covance, Inc. CAPS Rating: ****
ICLR $21.93 Up +0.48 +2.24%
ICON plc (ADR) CAPS Rating: ***
ILMN $43.84 Up +0.38 +0.87%
Illumina CAPS Rating: ****
LIFE $41.83 Down -0.18 -0.43%
Life Technologies… CAPS Rating: ****
PACB $2.60 Up +0.20 +8.33%
Pacific Bioscience… CAPS Rating: ***

Advertisement